Zhengye Biotechnology Holding Limited Class A Ordinary Shares (NASDAQ: ZYBT) last traded at $1.73, up 50.45% on the session. The quote above updates while this page is open; the figures below are drawn from Zhengye Biotechnology Holding Limited Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Zhengye Biotechnology Holding Limited Class A Ordinary Shares trades on NASDAQ under the ticker ZYBT. Its market capitalisation is $81.99 million.
Valuation measures for Zhengye Biotechnology Holding Limited Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $81.99M |
|---|---|
| Enterprise value | $93.35M |
| Price / sales | 4.93 |
| Price / book | 2.30 |
| Beta | -0.40 |
Trailing-twelve-month figures tagged in Zhengye Biotechnology Holding Limited Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $16.64M |
|---|---|
| Net income (TTM) | -$9.98M |
| Gross margin | 20.51% |
| Operating margin | -60.60% |
| Return on equity | -27.94% |
| Cash | $7.20M |
Range and volume for ZYBT over the past 52 weeks.
| 52-week high | $8.01 |
|---|---|
| 52-week low | $0.616 |
| Volume | 30.60M |
| Average volume | 5.48M |
| Previous close | $1.15 |
Invest a chosen dollar amount in Zhengye Biotechnology Holding Limited Class A Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ZYBT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.